NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
13.04
-1.19 (-8.36%)
At close: Mar 6, 2026, 4:00 PM EST
13.00
-0.04 (-0.30%)
After-hours: Mar 6, 2026, 7:42 PM EST
NovoCure Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for NovoCure stock have an average target of 28.08, with a low estimate of 14.5 and a high estimate of 49. The average target predicts an increase of 115.34% from the current stock price of 13.04.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for NovoCure stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $47 → $49 | Strong Buy | Maintains | $47 → $49 | +275.77% | Feb 26, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $39 → $47 | Strong Buy | Maintains | $39 → $47 | +260.43% | Feb 12, 2026 |
| Wedbush | Wedbush | Hold Reiterates $18 | Hold | Reiterates | $18 | +38.04% | Jan 15, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $42 → $39 | Strong Buy | Maintains | $42 → $39 | +199.08% | Jan 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $38 → $42 | Strong Buy | Maintains | $38 → $42 | +222.09% | Oct 30, 2025 |
Financial Forecast
Revenue This Year
705.96M
from 655.35M
Increased by 7.72%
Revenue Next Year
753.51M
from 705.96M
Increased by 6.74%
EPS This Year
-1.60
from -1.22
EPS Next Year
-1.28
from -1.60
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 732.5M | 823.2M | |||
| Avg | 706.0M | 753.5M | |||
| Low | 672.2M | 683.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.8% | 16.6% | |||
| Avg | 7.7% | 6.7% | |||
| Low | 2.6% | -3.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.39 | -1.17 | |||
| Avg | -1.60 | -1.28 | |||
| Low | -1.82 | -1.39 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.